Dr. Tory Prestera, MD, PhD

Dr. Prestera practices at Tory Prestera MD Inc. in San Marcos, California.

Dr. Prestera's NPI, 1346224557, was assigned on December 1, 2005. Dr. Prestera graduated from The Johns Hopkins University School of Medicine in 1994. Dr. Prestera holds California license A62321.

Dr. Prestera's primary practice is Tory Prestera MD Inc., at 100 N Rancho Santa Fe Rd, San Marcos, CA 92069 in San Diego County. The practice phone is (760) 598-0400.

Dr. Prestera's primary practice is Tory Prestera MD Inc. in San Marcos, California. Dmand AI also links Dr. Prestera to 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Prestera practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Prestera's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Prestera is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Prestera's licenses on file in 3 states: California, Tennessee and Georgia.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, conjunctivitis, dry eye, eye infection or inflammation, eyelid inflammation and glaucoma among the conditions Dr. Prestera treats.

CMS data shows 18,490 Medicare services from Dr. Prestera across 24 procedure codes in 2024, for 456 Medicare patients. Medicare paid $664,678 for them.

CMS counts 456 Medicare patients who saw Dr. Prestera in 2024. The largest group is 65 to 74, with 224 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 75% are also on Medicaid. Their average risk score is 2.05, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Prestera's median patient age at 65, with 61% women.

In 2024, Dr. Prestera wrote 1,847 Medicare Part D claims for 389 patients. 64% of them were for generic drugs. CMS names the drug for 1,756 of them, across 13 drugs with 11 or more claims each, at $41,396 in total drug cost. In 2023, CMS named 1,807 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Prestera for performance year 2024, reported as part of a group. Dr. Prestera accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 57 procedures of cataract surgery by Dr. Prestera, more than 65% of the clinicians it reports for that procedure.

Dmand AI links 10 papers to Dr. Prestera. The most frequent topics are NAD(P)H Dehydrogenase (Quinone), Enzyme Induction and Glutathione Transferase. Dr. Prestera has published most often in Anal Biochem.

CMS Open Payments shows 59 general payments to Dr. Prestera from 15 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 94% of the total. Alcon Laboratories Inc paid the most, $567.

Dr. Prestera graduated from The Johns Hopkins University School of Medicine in 1994.

Dr. Prestera is in network with 14 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.